Cillian King, PhD joined LSP in 2021 as an Investment Manager. His primary responsibility within LSP is to invest in private companies, primarily through the LSP Dementia Fund.
Prior to joining LSP, Cillian was an Investment Manager at Swanbridge Capital, a venture fund focused on early-stage life sciences companies. At Swanbridge, Cillian led and managed seed investments into biotech companies and served on the Boards of Allero Therapeutics and Pan Cancer T. Previously, Cillian worked as a consultant, where he advised a wide range of companies across the life sciences industry. He was also instrumental in structuring and launching two venture funds.
Cillian has a Bachelor’s degree in biomedical sciences and a Master’s degree in neurosciences, both from the VU University (Amsterdam, NL). He performed research on neurodegenerative diseases at MIT (Cambridge, USA) and holds a PhD in molecular neurosciences from the VU University. His academic research was focused on synaptic plasticity and ciliary signalling and was published in leading scientific journals, including EMBO.
Cillian lives in Amsterdam with his wife and two children.
